ACS Omega
(Feb 2022)
Doxorubicin–NO Releaser Molecular Hybrid Activatable by Green Light to Overcome Resistance in Breast Cancer Cells
- Cristina Parisi,
- Francesca Moret,
- Aurore Fraix,
- Luca Menilli,
- Mariacristina Failla,
- Federica Sodano,
- Claudia Conte,
- Fabiana Quaglia,
- Elena Reddi,
- Salvatore Sortino
Affiliations
- Cristina Parisi
- Department of Drug and Health Sciences, University of Catania, Catania, Italy
- Francesca Moret
- Department of Biology, University of Padova, Padova, Italy
- Aurore Fraix
- Department of Drug and Health Sciences, University of Catania, Catania, Italy
- Luca Menilli
- Department of Biology, University of Padova, Padova, Italy
- Mariacristina Failla
- Department of Science and Drug Technology, University of Torino, Torino, Italy
- Federica Sodano
- Department of Drug and Health Sciences, University of Catania, Catania, Italy
- Claudia Conte
- Drug Delivery Laboratory, Department of Pharmacy, University of Napoli Federico II, Napoli, Italy
- Fabiana Quaglia
- Drug Delivery Laboratory, Department of Pharmacy, University of Napoli Federico II, Napoli, Italy
- Elena Reddi
- Department of Biology, University of Padova, Padova, Italy
- Salvatore Sortino
- Department of Drug and Health Sciences, University of Catania, Catania, Italy
- DOI
-
https://doi.org/10.1021/acsomega.1c03988
- Journal volume & issue
-
Vol. 7,
no. 9
pp.
7452
– 7459
WeChat QR code